Medical devices PLI extended to FY 2035-36, fresh applications invited
Department of Pharmaceuticals
Companies and LLPs can apply afresh in four segments, including critical components, for incentives of 3% to 10% of incremental sales over five years. In three segments, a Rs 50 crore minimum investment applies only below Rs 150 crore turnover.
Read more: Medical devices PLI extended to FY 2035-36, fresh applications invited